EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H21N3O3S |
| Net Charge | 0 |
| Average Mass | 323.418 |
| Monoisotopic Mass | 323.13036 |
| SMILES | Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1 |
| InChI | InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19) |
| InChIKey | BOVGTQGAOIONJV-UHFFFAOYSA-N |
| Roles Classification |
|---|
| ChEBI Ontology |
|---|
| IUPAC Name |
|---|
| N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide |
| Synonyms | Source |
|---|---|
| Gliclazide | ChemIDplus |
| Glimicron | ChemIDplus |
| 1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea | ChemIDplus |
| 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| D01599 | KEGG DRUG |
| DB01120 | DrugBank |
| HMDB0015252 | HMDB |
| Gliclazide | Wikipedia |
| LSM-5096 | LINCS |
| 1299 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:1657836 | Reaxys |
| CAS:21187-98-4 | KEGG DRUG |
| CAS:21187-98-4 | ChemIDplus |
| Citations |
|---|